Aligos Therapeutics, Inc. (ALGS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US01626L2043
Aligos Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.19 m USD |
| Operating income | -87.99 m USD |
| EBIT | -23.88 m USD |
| Net income | -24.19 m USD |
| Diluted EPS – continuing operations | -2.45 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
More stocks
- CYBERLOQ TECHNOLOGIES, INC. (CLOQ)
- AMC Robotics Corp (AMCI)
- CIRCLE8 GROUP INC (CIRC)
- PETMED EXPRESS INC (PETS)
- TScan Therapeutics, Inc. (TCRX)
- NOCOPI TECHNOLOGIES INC/MD/ (NNUP)
- WM TECHNOLOGY, INC. (MAPS)
- VenHub Global, Inc. (VHUB)
- Lung Ming Green Energy Technology Engineering Co Ltd (3018.TW)
- DocGo Inc. (DCGO)
- MEXCO ENERGY CORP (MXC)
- Alset Inc. (AEI)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.